$QCLS
Q/C Technologies, Inc. Common Stock
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
$0.760
▼-21.17%-$0.204
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateQ/C Technologies, Inc. Common Stock
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
Why is QCLS down today? It is at $0.760 (-21.17%), and our scanner flagged it 126 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment QCLS spikes, and full due diligence on QCLS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $QCLS 126 times in the last 30 days. Create a free account to track $QCLS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on QCLS from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Silverman Joshua Officer | Acquired (grant/award) | +162K 2.0% of company | added 100% | 262K | n/a | Apr 13, 26 |
Voss Chelsea Sierra Director | Bought (open market) | +2K 0.02% of company | added 2.9% | 62K | $6K at $3.15 | Mar 30, 26 |
Voss Chelsea Sierra Director | Acquired (grant/award) | +238K 2.9% of company | added 100% | 240K | n/a | Jan 16, 26 |
Rauch Gary M Other | Acquired (grant/award) | +11K 0.1% of company | added 100% | 13K | n/a | Nov 14, 25 |
Bernstein Bruce Director | Acquired (grant/award) | +25K 0.3% of company | n/a | 25K | n/a | Nov 14, 25 |
Friscia Stephen Director | Acquired (grant/award) | +23K 0.3% of company | added 100% | 25K | n/a | Nov 14, 25 |
Silverman Joshua Officer | Acquired (grant/award) | +91K 1.1% of company | added 100% | 100K | n/a | Nov 14, 25 |
Glass Mitchell Officer | Acquired (grant/award) | +11K 0.1% of company | added 100% | 13K | n/a | Nov 14, 25 |
White Billy Joe Director | Acquired (grant/award) | +23K 0.3% of company | added 100% | 25K | n/a | Nov 14, 25 |
Rauch Gary M Other | Acquired (grant/award) | +1K 0.01% of company | n/a | 1K | n/a | Oct 3, 25 |
White Billy Joe Director | Acquired (grant/award) | +2K 0.03% of company | added 100% | 2K | n/a | Oct 3, 25 |
Glass Mitchell Officer | Acquired (grant/award) | +1K 0.01% of company | n/a | 1K | n/a | Oct 3, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
Here is the latest on QCLS from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
QCLS last traded at $0.760, down 21.17% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The QCLS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged QCLS 126 times in the last 30 days.
QCLS (Q/C Technologies, Inc. Common Stock) trades on XNAS, with a market cap of about $8M in the In Vitro & In Vivo Diagnostic Substances sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge QCLS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$QCLS discussion
Sign in to ask a question or join the discussion.